Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (3): 215-221.DOI: 10.3969/j.issn.1673-8640.2024.03.002
Previous Articles Next Articles
LIU Mengzhu1, GU Jinyun1, ZHU Xia2, CHEN Xia1()
Received:
2022-07-04
Revised:
2023-07-27
Online:
2024-03-30
Published:
2024-04-24
CLC Number:
LIU Mengzhu, GU Jinyun, ZHU Xia, CHEN Xia. Predictive value of glucose variability parameters before delivery for macrosomia in patients with gestational diabetes mellitus[J]. Laboratory Medicine, 2024, 39(3): 215-221.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.03.002
组别 | 例数 | 胎龄/周 | 体重/kg | 身长/cm | 性别 | 血糖/(mmol·L-1) | |
---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | ||||||
GDM巨大儿组 | 46 | 38.22±1.63 | 4.33±0.28 | 55.91±1.34 | 20(43.48) | 26(56.52) | 2.43±0.31 |
GDM健康儿组 | 54 | 38.43±2.12 | 3.24±0.50* | 50.67±3.23* | 23(42.59) | 31(57.41) | 2.48±0.43 |
巨大儿对照组 | 50 | 38.14±1.87 | 4.30±0.19# | 54.82±1.45# | 21(42.00) | 29(58.00) | 2.76±0.27*# |
健康儿对照组 | 211 | 38.46±1.58 | 3.21±0.45*△ | 49.33±3.41*△ | 89(42.18) | 122(57.82) | 2.79±0.30*# |
统计值 | 0.533 | 13.129 | 18.952 | 0.030 | 5.573 | ||
P值 | 0.596 | <0.001 | <0.001 | 0.999 | <0.001 |
组别 | 例数 | 胎龄/周 | 体重/kg | 身长/cm | 性别 | 血糖/(mmol·L-1) | |
---|---|---|---|---|---|---|---|
男/[例(%)] | 女/[例(%)] | ||||||
GDM巨大儿组 | 46 | 38.22±1.63 | 4.33±0.28 | 55.91±1.34 | 20(43.48) | 26(56.52) | 2.43±0.31 |
GDM健康儿组 | 54 | 38.43±2.12 | 3.24±0.50* | 50.67±3.23* | 23(42.59) | 31(57.41) | 2.48±0.43 |
巨大儿对照组 | 50 | 38.14±1.87 | 4.30±0.19# | 54.82±1.45# | 21(42.00) | 29(58.00) | 2.76±0.27*# |
健康儿对照组 | 211 | 38.46±1.58 | 3.21±0.45*△ | 49.33±3.41*△ | 89(42.18) | 122(57.82) | 2.79±0.30*# |
统计值 | 0.533 | 13.129 | 18.952 | 0.030 | 5.573 | ||
P值 | 0.596 | <0.001 | <0.001 | 0.999 | <0.001 |
组别 | 例数 | 年龄 | 孕前体重指数 | 文化程度 | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
<30岁/ [例(%)] | ≥30岁/ [例(%)] | <25 kg·m-2/[例(%)] | ≥25 kg·m-2/[例(%)] | 高中及以下/[例(%)] | 大专或本科/[例(%)] | 本科以上/ [例(%)] | ||||||||||||||||||||||
GDM巨大儿组 | 46 | 12(26.09) | 34(73.91) | 21(45.65) | 25(54.35) | 13(28.26) | 20(43.48) | 13(28.26) | ||||||||||||||||||||
GDM健康儿组 | 54 | 14(25.93) | 40(74.07) | 25(46.30) | 29(53.70) | 15(27.78) | 23(42.59) | 16(29.63) | ||||||||||||||||||||
巨大儿对照组 | 50 | 13(26.00) | 37(74.00) | 23(46.00) | 27(54.00) | 14(28.00) | 21(42.00) | 15(30.00) | ||||||||||||||||||||
健康儿对照组 | 211 | 54(25.59) | 157(74.41) | 97(45.97) | 114(54.03) | 59(27.96) | 89(42.18) | 63(29.86) | ||||||||||||||||||||
统计值 | 0.008 | 0.204 | 5.153 | |||||||||||||||||||||||||
P值 | 1.000 | 0.743 | 0.161 | |||||||||||||||||||||||||
组别 | 不良妊娠史/[例(%)] | 糖尿病家族史/[例(%)] | 孕期体重增长 | 孕次 | ||||||||||||||||||||||||
≤12.5 kg/[例(%)] | >12.5 kg /[例(%)] | 1次/[例(%)] | ≥2次/[例(%)] | |||||||||||||||||||||||||
GDM巨大儿组 | 16(34.78) | 18(39.13) | 21(45.65) | 25(54.35) | 34(73.91) | 12(26.09) | ||||||||||||||||||||||
GDM健康儿组 | 19(35.19) | 22(40.74) | 25(46.30) | 29(53.70) | 40(74.07) | 14(25.93) | ||||||||||||||||||||||
巨大儿对照组 | 18(36.00) | 20(40.00) | 23(46.00) | 27(54.00) | 37(74.00) | 13(26.00) | ||||||||||||||||||||||
健康儿对照组 | 76(36.02) | 85(40.28) | 97(45.97) | 114(54.03) | 157(74.41) | 54(25.59) | ||||||||||||||||||||||
统计值 | 4.276 | 8.437 | 0.204 | 0.008 | ||||||||||||||||||||||||
P值 | 0.205 | 0.092 | 0.743 | 1.000 | ||||||||||||||||||||||||
组别 | 产次 | FBG/(mmol·L-1) | 2 h PG/(mmol·L-1) | TG/(mmol·L-1) | TC/(mmol·L-1) | LDL-C/(mmol·L-1) | ||||||||||||||||||||||
1次/[例(%)] | ≥2次/[例(%)] | |||||||||||||||||||||||||||
GDM巨大儿组 | 39(84.78) | 7(15.22) | 9.29±0.86 | 9.74±1.96 | 2.62±0.52 | 4.81±1.04 | 3.03±0.97 | |||||||||||||||||||||
GDM健康儿组 | 46(85.19) | 8(14.81) | 8.57±0.43* | 9.00±1.24* | 1.99±0.47* | 4.76±1.01 | 2.67±0.96* | |||||||||||||||||||||
巨大儿对照组 | 43(86.00) | 7(14.00) | 5.81±0.15*# | 6.50±0.86*# | 1.47±0.33*# | 4.53±0.94 | 2.16±0.32*# | |||||||||||||||||||||
健康儿对照组 | 181(85.78) | 30(14.22) | 5.79±0.13*# | 6.49±0.16*# | 1.48±0.25*# | 4.52±0.91 | 2.15±0.27*# | |||||||||||||||||||||
统计值 | 0.223 | 5.412 | 2.289 | 6.361 | 2.243 | 2.300 | ||||||||||||||||||||||
P值 | 0.872 | <0.001 | 0.024 | <0.001 | 0.808 | 0.022 | ||||||||||||||||||||||
组别 | HDL-C/(mmol·L-1) | HbA1c/% | apo A/ (g·L-1) | apo B/ (g·L-1) | MAGE/(mmol·L-1) | PPGE/(mmol·L-1) | MODD/(mmol·L-1) | |||||||||||||||||||||
GDM巨大儿组 | 0.77±0.19 | 8.73±0.74 | 0.32±0.03 | 0.59±0.14 | 4.17±1.35 | 2.98±0.75 | 4.75±0.91 | |||||||||||||||||||||
GDM健康儿组 | 0.86±0.21* | 7.67±0.69* | 0.40±0.05* | 0.45±0.10* | 3.58±1.01* | 2.76±0.83* | 4.24±0.81* | |||||||||||||||||||||
巨大儿对照组 | 1.36±0.28*# | 5.36±0.53*# | 0.46±0.09*# | 0.37±0.09*# | 3.05±0.73*# | 2.03±0.42*# | 3.26±0.33*# | |||||||||||||||||||||
健康儿对照组 | 1.37±0.32*# | 5.35±0.48*# | 0.46±0.10*# | 0.38±0.15*# | 2.99±0.68*# | 1.95±0.14*# | 3.24±0.32*# | |||||||||||||||||||||
统计值 | 3.091 | 9.318 | 2.068 | 5.519 | 2.304 | 2.893 | 2.965 | |||||||||||||||||||||
P值 | 0.002 | <0.001 | 0.041 | <0.001 | 0.023 | 0.005 | 0.004 |
组别 | 例数 | 年龄 | 孕前体重指数 | 文化程度 | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
<30岁/ [例(%)] | ≥30岁/ [例(%)] | <25 kg·m-2/[例(%)] | ≥25 kg·m-2/[例(%)] | 高中及以下/[例(%)] | 大专或本科/[例(%)] | 本科以上/ [例(%)] | ||||||||||||||||||||||
GDM巨大儿组 | 46 | 12(26.09) | 34(73.91) | 21(45.65) | 25(54.35) | 13(28.26) | 20(43.48) | 13(28.26) | ||||||||||||||||||||
GDM健康儿组 | 54 | 14(25.93) | 40(74.07) | 25(46.30) | 29(53.70) | 15(27.78) | 23(42.59) | 16(29.63) | ||||||||||||||||||||
巨大儿对照组 | 50 | 13(26.00) | 37(74.00) | 23(46.00) | 27(54.00) | 14(28.00) | 21(42.00) | 15(30.00) | ||||||||||||||||||||
健康儿对照组 | 211 | 54(25.59) | 157(74.41) | 97(45.97) | 114(54.03) | 59(27.96) | 89(42.18) | 63(29.86) | ||||||||||||||||||||
统计值 | 0.008 | 0.204 | 5.153 | |||||||||||||||||||||||||
P值 | 1.000 | 0.743 | 0.161 | |||||||||||||||||||||||||
组别 | 不良妊娠史/[例(%)] | 糖尿病家族史/[例(%)] | 孕期体重增长 | 孕次 | ||||||||||||||||||||||||
≤12.5 kg/[例(%)] | >12.5 kg /[例(%)] | 1次/[例(%)] | ≥2次/[例(%)] | |||||||||||||||||||||||||
GDM巨大儿组 | 16(34.78) | 18(39.13) | 21(45.65) | 25(54.35) | 34(73.91) | 12(26.09) | ||||||||||||||||||||||
GDM健康儿组 | 19(35.19) | 22(40.74) | 25(46.30) | 29(53.70) | 40(74.07) | 14(25.93) | ||||||||||||||||||||||
巨大儿对照组 | 18(36.00) | 20(40.00) | 23(46.00) | 27(54.00) | 37(74.00) | 13(26.00) | ||||||||||||||||||||||
健康儿对照组 | 76(36.02) | 85(40.28) | 97(45.97) | 114(54.03) | 157(74.41) | 54(25.59) | ||||||||||||||||||||||
统计值 | 4.276 | 8.437 | 0.204 | 0.008 | ||||||||||||||||||||||||
P值 | 0.205 | 0.092 | 0.743 | 1.000 | ||||||||||||||||||||||||
组别 | 产次 | FBG/(mmol·L-1) | 2 h PG/(mmol·L-1) | TG/(mmol·L-1) | TC/(mmol·L-1) | LDL-C/(mmol·L-1) | ||||||||||||||||||||||
1次/[例(%)] | ≥2次/[例(%)] | |||||||||||||||||||||||||||
GDM巨大儿组 | 39(84.78) | 7(15.22) | 9.29±0.86 | 9.74±1.96 | 2.62±0.52 | 4.81±1.04 | 3.03±0.97 | |||||||||||||||||||||
GDM健康儿组 | 46(85.19) | 8(14.81) | 8.57±0.43* | 9.00±1.24* | 1.99±0.47* | 4.76±1.01 | 2.67±0.96* | |||||||||||||||||||||
巨大儿对照组 | 43(86.00) | 7(14.00) | 5.81±0.15*# | 6.50±0.86*# | 1.47±0.33*# | 4.53±0.94 | 2.16±0.32*# | |||||||||||||||||||||
健康儿对照组 | 181(85.78) | 30(14.22) | 5.79±0.13*# | 6.49±0.16*# | 1.48±0.25*# | 4.52±0.91 | 2.15±0.27*# | |||||||||||||||||||||
统计值 | 0.223 | 5.412 | 2.289 | 6.361 | 2.243 | 2.300 | ||||||||||||||||||||||
P值 | 0.872 | <0.001 | 0.024 | <0.001 | 0.808 | 0.022 | ||||||||||||||||||||||
组别 | HDL-C/(mmol·L-1) | HbA1c/% | apo A/ (g·L-1) | apo B/ (g·L-1) | MAGE/(mmol·L-1) | PPGE/(mmol·L-1) | MODD/(mmol·L-1) | |||||||||||||||||||||
GDM巨大儿组 | 0.77±0.19 | 8.73±0.74 | 0.32±0.03 | 0.59±0.14 | 4.17±1.35 | 2.98±0.75 | 4.75±0.91 | |||||||||||||||||||||
GDM健康儿组 | 0.86±0.21* | 7.67±0.69* | 0.40±0.05* | 0.45±0.10* | 3.58±1.01* | 2.76±0.83* | 4.24±0.81* | |||||||||||||||||||||
巨大儿对照组 | 1.36±0.28*# | 5.36±0.53*# | 0.46±0.09*# | 0.37±0.09*# | 3.05±0.73*# | 2.03±0.42*# | 3.26±0.33*# | |||||||||||||||||||||
健康儿对照组 | 1.37±0.32*# | 5.35±0.48*# | 0.46±0.10*# | 0.38±0.15*# | 2.99±0.68*# | 1.95±0.14*# | 3.24±0.32*# | |||||||||||||||||||||
统计值 | 3.091 | 9.318 | 2.068 | 5.519 | 2.304 | 2.893 | 2.965 | |||||||||||||||||||||
P值 | 0.002 | <0.001 | 0.041 | <0.001 | 0.023 | 0.005 | 0.004 |
[1] |
HE J, WANG Y, LIU Y, et al. Experiences of pregnant women with gestational diabetes mellitus:a systematic review of qualitative evidence protocol[J]. BMJ Open, 2020, 10(2):e034126.
DOI URL |
[2] | DUNN A B, HANSON L, VANDEVUSSE L, et al. Through the microbial looking glass:premature labor,preeclampsia,and gestational diabetes[J]. J Perinat Neonatal Nurs, 2019, 33(1):35-51. |
[3] | 中华医学会妇产科学分会产科学组, 中华医学会围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南(2014)[J]. 中华妇产科杂志, 2014, 49(8):561-569. |
[4] | 中华医学会儿科学分会. 新生儿疾病诊疗规范[M]. 北京: 人民卫生出版社, 2016. |
[5] |
MA Y, LI S, WEI X, et al. Comparison of serum concentrations of humanin in women with and without gestational diabetes mellitus[J]. Gynecol Endocrinol, 2018, 34(12):1064-1067.
DOI PMID |
[6] |
KISHIMOTO M, KATO R, OSHIBA Y. Impact of dietary counseling on the perception of diet in patients with gestational diabetes mellitus[J]. Diabetol Int, 2020, 12(2):151-160.
DOI |
[7] | 孟晓瑜, 王艳, 思美丽, 等. 胎盘胰岛素样生长因子1、胰岛素样生长因子2与妊娠期糖尿病巨大儿糖脂代谢的关系[J]. 医学综述, 2016, 22(19):3899-3901. |
[8] |
ALHARBI K K, ALSAIKHAN A S, ALSHAMMARY A F, et al. Screening of mitochondrial mutations in Saudi women diagnosed with gestational diabetes mellitus:a non-replicative case-control study[J]. Saudi J Biol Sci, 2022, 29(1):360-365.
DOI URL |
[9] |
BIANCO M E, JOSEFSON J L. Hyperglycemia during pregnancy and long-term offspring outcomes[J]. Curr Diab Rep, 2019, 19(12):143.
DOI |
[10] | MARTIS R, CROWTHER C A, SHEPHERD E, et al. Treatments for women with gestational diabetes mellitus:an overview of Cochrane systematic reviews[J]. Cochrane Database Syst Rev, 2018, 8(8):CD012327. |
[11] | 黄斌, 麦世龙, 刘伯奇, 等. 糖化白蛋白、糖化血红蛋白、血糖联合检测在2型糖尿病患者诊断中的应用评价分析[J]. 中国卫生检验杂志, 2017, 27(14):2038-2040. |
[12] |
CRAIG L, SIMS R, GLASZIOU P, et al. Women's experiences of a diagnosis of gestational diabetes mellitus:a systematic review[J]. BMC Pregnancy Childbirth, 2020, 20(1):76.
DOI |
[13] |
DAYYANI I, TERKILDSEN MAINDAL H, ROWLANDS G, et al. A qualitative study about the experiences of ethnic minority pregnant women with gestational diabetes[J]. Scand J Caring Sci, 2019, 33(3):621-631.
DOI PMID |
[14] | DALFRÀ M G, VESCOVO G G D, BURLINA S, et al. Celiac disease and pregnancy outcomes in patients with gestational diabetes mellitus[J]. Int J Endocrinol, 2020, 2020:5295290. |
[15] | 何競, 周晓惠, 王广宇, 等. 体质指数与2型糖尿病患者糖化白蛋白及糖化白蛋白与糖化血红蛋白比值的相关性研究[J]. 实用心脑肺血管病杂志, 2019, 27(6):48-52. |
[16] |
CHEN M, YAN J, HAN Q, et al. Identification of hub-methylated differentially expressed genes in patients with gestational diabetes mellitus by multi omic WGCNA basing epigenome wide and transcriptome wide profiling[J]. J Cell Biochem, 2020, 121(5-6):3173-3184.
DOI URL |
[17] |
程晨, 张越, 何奖图, 等. 糖化血红蛋白及糖化白蛋白在妊娠期糖尿病诊断中的价值[J]. 检验医学, 2014, 29(2):135-138.
DOI |
[1] | CHEN Hui, CHEN Guanghui, LIANG Yingliang, WANG Wandang, YIN Zhijun. Screening hub genes and diagnostic analysis of gestational diabetes mellitus based on GEO database [J]. Laboratory Medicine, 2023, 38(3): 276-281. |
[2] | KE Qiulei, HUANG Jing, CHEN Aizheng, SONG Yanfeng, SU Xiaofeng. Subgingival flora and the relations between periodontal health indexes and risk of periodontal disease in patients with GDM [J]. Laboratory Medicine, 2023, 38(2): 163-166. |
[3] | QIAN Linyu, LIANG Weifang, TANG Sichen. Determination and clinical significance of NLRP3,CTRP6 and IL-1β in patients with gestational diabetes mellitus [J]. Laboratory Medicine, 2023, 38(10): 936-940. |
[4] | WANG Lingling, REN Chunli. Correlation of MTHFR gene C677T polymorphism and blood lipid levels with GDM [J]. Laboratory Medicine, 2022, 37(6): 543-546. |
[5] | ZHANG Xiaoqin, ZHOU Yulan, FU Zhumei, HAN Xuexue, ZHAN Jie. Relationship of mtDNA T16189C mutation and gestational diabetes mellitus [J]. Laboratory Medicine, 2022, 37(5): 413-416. |
[6] | LE Jiangman, LI Tianyuan, TAN Meiyu, WANG Yajie, ZHOU Lida, SHU Jie, WU Jiaoxiang, SUN Hanxiao, XUAN Binbin, CAI Xushan, SHENG Huiming. Correlation of gestational diabetes mellitus with plasma TMAO [J]. Laboratory Medicine, 2021, 36(8): 795-799. |
[7] | WANG Yu, ZHANG Wenwen, LIU Meiling, LIU Xiaojuan. Relationship between AFP,free-βHCG,uE3 and GDM in the second trimester of pregnancy [J]. Laboratory Medicine, 2021, 36(8): 828-832. |
[8] | CHEN Xingyu, DONG Feifei. Correlation between fasting blood glucose variability parameters and painful diabetic peripheral neuropathy [J]. Laboratory Medicine, 2021, 36(3): 285-291. |
[9] | ZHOU Lifang, PAN Shun, TANG Zhenhua. Application of Raman spectroscopy in the diagnosis of gestational diabetes mellitus [J]. Laboratory Medicine, 2021, 36(3): 313-317. |
[10] | XU Zhen, MA Lijuan, WU Siyi, WANG Yan, JIA Keke. Predictive role of serum fibronectin level in the second trimester of pregnancy for patients with gestational diabetes mellitus complicated with preeclampsia [J]. Laboratory Medicine, 2020, 35(6): 561-565. |
[11] | YOU Xiuzhen. Predictive value of body mass index and triglyceride level changes in early pregnancy on gestational diabetes mellitus [J]. Laboratory Medicine, 2019, 34(9): 831-834. |
[12] | ZHANG Kainan, ZHANG Zhaoxia. Role of gut microbiota in gestational obesity and diabetes mellitus [J]. Laboratory Medicine, 2019, 34(3): 276-279. |
[13] | JIN Yuewen, YUE Chaoyan, YING Chunmei. Roles of glycated hemoglobin A1c and glycated albumin in screening gestational diabetes mellitus among elderly pregnant women [J]. Laboratory Medicine, 2018, 33(4): 312-315. |
[14] | ZHANG Chunyi, NI Yinghua, JI Xin, YING Chunmei. Correlation of neonate birth weight with glycated hemoglobin A1c and glycated albumin levels in patients with gestational diabetes mellitus [J]. Laboratory Medicine, 2017, 32(3): 165-168. |
[15] | ZHANG Xianghui, ZHAO Yuanming, SUN Zhuoxiang, CHENG Panpan, JIN Chao. Correlation study of serum ferritin and high-sensitivity C reactive protein in gestational diabetes mellitus [J]. Laboratory Medicine, 2015, 30(9): 903-905. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||